Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial.-MedSci.cn

Early clearance of plasma EGFR mutations as a predictor of response to osimertinib and comparator EGFR-TKIs in the FLAURA trial.

Zhou, CC; Imamura, F; Cheng, Y; Okamoto, I; Cho, BC; Lin, MC; Majem, M; Gautschi, O; Gray, JE; Boyer, MJ; Chmielecki, J; Hartmaier, R; Bulusu, K; Barrett, JC; Hodge, R; Saggese, M; McKeown, A; Ramalingam, SS

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务